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Human herpesvirus 6 (HHV-6) is a lymphotropic herpesvirus, and in vitro, it can productively infect many
of the same cell types that human immunodeficiency virus (HIV) infects. Simultaneous infection of T cells by
HIV and HHV-6 can lead to both activation of the HIV promoter and acceleration of the cytopathic effects.
Several HHV-6 genes have been demonstrated to activate HIV promoter expression. Among them is a cDNA
clone, pCD41 (U27), which codes for the HHV-6 DNA polymerase accessory protein. We have now further
characterized the transcription pattern in the pCD41 locus and identified at least six RNA species, ranging in
size from 1.2 to 4.5 kb. Northern (RNA) blot analyses showed no significant difference in RNA patterns between
the HHV-6 variant A (GS) and variant B (Z29) viruses. All the RNA species detected by pCD41 are polyad-
enylated and polyribosome associated, suggesting that they may be actively engaged in protein synthesis.
Cycloheximide and phosphonoacetic acid inhibition assay results indicate that all the pCD41 RNA species
belong to the herpesviral early-late family. Using primer extension and S1 mapping techniques, the 5* and 3*
ends of each transcript were mapped to different positions, and no splicing was observed.
Human herpesvirus 6 (HHV-6) is a lymphotropic herpesvi-
rus that was first isolated from the peripheral blood lympho-
cytes of patients with lymphoproliferative disorders and AIDS
(13, 26, 49, 55). Serological studies have shown that HHV-6 is
highly prevalent in the general population and that the sero-
positivity rate exceeds 90% (24, 25, 30, 49). HHV-6 is the
causative agent of exanthem subitum (54) and has been impli-
cated as a cofactor in the pathogenesis of AIDS (28, 35). In
vitro, HHV-6 productively infects many of the same cell types
as human immunodeficiency virus (HIV), particularly CD41
human T cells. Although HHV-6 has a primary tropism for
CD41 T cells, HHV-6 also infects and kills CD81 T cells,
natural killer cells, mononuclear phagocytes, and neural cells
(19, 33, 34, 36, 48, 53). HHV-6 infection induces the expression
of CD4 molecules in the CD81 T cells which are generally
refractory to HIV infection, and these cells become susceptible
to HIV infection (34). Coinfection of T cells with HIV and
HHV-6 leads to activation of the HIV long terminal repeat
(LTR)-directed viral gene expression and can accelerate the
cytopathic effects of HIV (14, 33). Furthermore, several
HHV-6 genes responsible for trans-activation of the HIV LTR
have been identified (16, 21, 22, 27, 37, 39, 59, 60). Besides
activating HIV gene expression, HHV-6 also suppresses HIV
type 1 replication in vitro (8, 31). Thus, HHV-6 could act as an
important cofactor in the pathogenesis of AIDS by regulating
the expression of HIV genes and/or by expanding the suscep-
tible host range for HIV infection.
The double-stranded DNA genome of HHV-6 is about 167
kb in size and consists of a 143-kb unique region flanked by 8-
to 13-kb direct repeats (17, 26, 42). The genome can potentially
encode over 102 proteins (17). Using monoclonal antibodies,
we previously identified an HHV-6(GS) cDNA clone, pCD41,
now known as U27, which encodes a 41-kDa nuclear phospho-
protein (p41) (9). This protein is conserved among all HHV-6
strains and shows strong homology with the human cytomeg-
alovirus (HCMV) UL44 gene coding for the ICP36 family of
early-late-class phosphoprotein (4, 9). Its location in the
HHV-6 genome is analogous to the location of UL44 in the
HCMV genome. The HCMV UL44 gene product is an acces-
sory protein for HCMV viral DNA polymerase and plays an
important role in viral replication (15). HHV-6 p41 has been
shown to bind DNA with the same affinity as HCMVUL44 and
hence is likely to be essential for HHV-6 replication (4). Re-
cently, we showed that both pCD41 cDNA clone and its
genomic clone, pGD41, can trans-activate HIV LTR-directed
gene expression in CV-1 cells, suggesting that the pCD41 gene
locus may be involved in gene regulation as well as potentially
in viral DNA replication. The pCD41 locus encodes two open
reading frames (ORFs), ORF A and ORF B. The p41 protein
is encoded by ORF A, and a 27-kDa protein can potentially be
encoded by ORF B. The C-terminal half of p41 was shown to
be responsible for the trans-activation activity, and the NF-kB
binding sites on the HIV LTR appear to be important for
activation (60). Deletion constructs in the pCD41 cDNA clone
suggested that the trans-activation is mediated by the putative
gene product from ORF A and that a putative internal pro-
moter can be used to transcribe a protein with trans-activating
function. Downstream of this promoter region, there were
three ATG codons in the same ORF, and translation in any of
these three codons could result in the synthesis of three over-
lapping proteins of 18, 16, and 14 kDa. In order to determine
whether such a transcript exists and whether such truncated
trans-activating proteins can be made, it is important to iden-
tify the transcripts that are encoded by this gene locus. Multi-
ple RNA species (4.5, 2.6/2.5, 2.1, 1.8/1.7, and 1.2 kb) in HHV-
6(GS)-infected HSB-2 cells were found to hybridize to the
pCD41 probe (4, 9), suggesting that this gene locus may even
encode for different gene products. Since this gene locus seems
to be involved in viral gene regulation, detailed analyses of this
region should provide important information on how HHV-6
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regulates its gene expression, replicates its DNA, and interacts
with other viruses, especially HIV.
In this study, we have shown that at least six different RNA
species can hybridize to the pCD41 probe in Northern (RNA)
blot analyses and that all of them are transcribed from the
same orientation. These RNA species belongs to the early-late
gene family. They are polyadenylated and associated with
polyribosomes, suggesting that they may be translated. Our
RNA mapping results suggest that the 2.3- and 1.5-kb RNA
species could encode p41 protein in the ORF A and that the
1.2-kb RNA may encode a protein of about 17 kDa within
ORF B.
MATERIALS AND METHODS
Plasmids, clones, cells, and viral infection. The construction of pCD41 and
pGD41 encoding the HHV-6 p41 protein has been described previously (9). The
3.1-kb HHV-6 immediate-early (IE) gene cDNA clone was kindly given by F.
Neipel (50). Human T-cell lines HSB-2 (ATCC CCL 120.1), Molt-3 (ATCC CRL
1552), and J-Jhan were grown in RPMI 1640 medium (GIBCO-BRL) supple-
mented with 10% heat-inactivated fetal bovine serum and antibiotics. HHV-
6(GS) and HHV-6(Z29) were kindly given to us by R. Gallo and P. Pellett (26,
32, 46). HHV-6(GS) was propagated in either HSB-2 or J-Jhan cells, and HHV-
6(Z29) was propagated in Molt-3 or J-Jhan cells. Cocultivation was carried out
at a ratio of 1:5 infected cells/uninfected cells. After incubation at 378C for 2 h
or overnight, the cells were spun down and suspended in fresh medium with 10%
fetal bovine serum and antibiotics. Three days after infection, the media were
replaced. The infected cells were harvested when at least 70% of them displayed
cytopathic effects. To make high-titer virus stock, well-infected cells were pel-
leted and suspended into 1/10 of the original volume of medium. After three
freeze-thawing cycles, the cell debris was spun down at 3,000 3 g for 10 min and
the supernatant was either used immediately or kept at2808C for later infection.
DNA labeling. To generate the single-strand DNA (ssDNA) probes, the
pCD41 EcoRI insert was cloned into M13mp18 in different orientations. The
phages were purified by polyethylene glycol-NaCl precipitation, and ssDNA was
isolated by phenol-chloroform (1:1) extraction and ethanol precipitation (5).
Double-strand and ssDNA probes were labeled by the random primed labeling
method with a NEBblot kit (New England Biolabs). The oligonucleotides were
labeled by T4 DNA kinase with [g-32P]ATP (NEN; 6,000 Ci/mmol) at the 59 ends
by the standard method (7). To make a ssDNA probe for S1 mapping, 100 ng of
labeled oligonucleotides was annealed to 18 mg of ssDNA pCD41 template on
M13mp18, and then Klenow fragment (New England Biolabs) was added to
synthesize the probe. The labeled ssDNA strand was purified from a sequencing
gel after digestion with a suitable restriction enzyme.
The 39-end labeling was carried out with the Klenow fragment fill-in method.
Briefly, after digestion of pCD41 DNA with a restriction enzyme, the protruding
ends were filled in with Klenow fragment in the presence of a-32P-labeled
deoxynucleoside triphosphate ([a-32P]dNTP) (NEN; 3,000 Ci/mmol) and the
other three nucleotides at room temperature for 30 min. The labeled DNA was
then ethanol precipitated and digested with a suitable restriction enzyme. The
labeled ssDNA probe was electroeluted after separation in a sequencing gel.
Preparation of total RNA and of poly(A) and non-poly(A) RNAs. Total RNA
was extracted with commercial Trizol reagent (GIBCO-BRL) or guanidinium-
isothiocyanate as described elsewhere but with slight modification (7). Briefly,
the cells were suspended in guanidinium-isothiocyanate lysis buffer (4 M guani-
dinium-isothiocyanate, 20 mM sodium acetate [pH 5.2], 0.1 mM dithiothreitol
[DTT], 0.5% N-lauroylsarcosine) and passed through a 3-ml syringe with a
20-gauge needle four times to shear the high-molecular-weight cellular DNA.
The lysate was loaded onto a 5.7 M CsCl (prepared in deionized water) cushion
and centrifuged for 18 h in a Beckman SW41 rotor at 35,000 rpm and 188C. The
RNA pellet was suspended in 360 ml of TES (10 mM Tris-HCl [pH 7.4], 5 mM
EDTA, 1% sodium dodecyl sulfate [SDS]) solution and recovered by three
ethanol precipitations. Poly(A) RNA was separated from the total RNA by the
PolyATtract mRNA isolation system III (Promega). The separation was carried
out by following the procedures recommended by the manufacturer and retain-
ing the nonbinding supernatant as the non-poly(A) RNA fraction. After ethanol
precipitation, the RNA was then used for various studies.
Preparation of cytoplasmic and nuclear RNAs. Cell-free HHV-6(GS)-infected
HSB-2 cells were harvested at 4 days postinfection (p.i.) and suspended in lysis
buffer (10 mM Tris-HCl [pH 7.4], 10 mM NaCl, 3 mM MgCl2, 0.5% Nonidet
P-40) at 08C for 5 min to disrupt the cytoplasmic membrane. The cytoplasm and
nuclei were separated by low-speed centrifugation (500 3 g) for 5 min. The
supernatant containing cytoplasmic RNA was loaded onto a 0.2 M sucrose
gradient cushion in lysis buffer and spun at 8,000 rpm in a Beckman SW41 rotor
for 10 min. The top layer of the sucrose gradient was transferred to another tube
and mixed with an equal volume of guanidinium-isothiocyanate buffer for the
isolation of cytoplasmic RNA (7). The nucleus pellet from the low-speed cen-
trifugation was washed once with 20 ml of lysis buffer and then passed through
a 0.2 M sucrose cushion in the lysis buffer by centrifugation at 8,000 rpm in a
Beckman SW41 rotor for 10 min. The nucleus pellet was resuspended in guani-
dinium-isothiocyanate buffer for RNA isolation. Both cytoplasmic and nuclear
RNAs were purified with the CsCl cushion method as described earlier.
Preparation of polyribosome-associated RNA. At 4 days p.i., 2 3 107 cell-free
HHV-6(GS)-infected cells were incubated with 10 mg of cycloheximide (CHX)
per ml for 10 min before the cells were harvested. The cells were washed with
ice-cold phosphate-buffered saline, suspended in 1 ml of lysis buffer (20 mM
Tris-HCl [pH 8.0], 1.5 mM MgCl2, 140 mM KCl, 0.5 mM DTT, 0.1 mM CHX,
0.5% Nonidet P-40, 400 U of RNasin) and spun down at 1,000 rpm in a Beckman
GH3.8 rotor for 5 min. The supernatant was transferred to another tube and
centrifuged at 8,000 rpm in a Beckman SW41 rotor for 10 min to further remove
the nuclei and mitochondria. The supernatant (0.5 ml) was then loaded onto the
top of a 12-ml linear 20 to 47% sucrose gradient in 20 mM Tris-HCl (pH
8.0)–140 mM KCl with 5 mM MgCl2 or 10 mM EDTA. The gradients were
centrifuged for 2 h at 40,000 rpm in a Beckman SW41 rotor to separate the
polyribosomes. Fractions of about 1 ml each were collected from the bottom, and
the absorbency at 260 nm was measured. Two milliliters of guanidinium isothio-
cyanate RNA isolation buffer was added and then loaded onto a 5.7 M CsCl
cushion. After centrifugation for 18 h, the RNA was collected and then used in
Northern blot analysis (7).
CHX and phosphonoacetic acid (PAA) treatment. For CHX treatment, 8 3
107 HSB-2 cells were treated for 1 h with 2 mg of Polybrene per ml in medium
containing 100 mg of CHX per ml. The cells were then spun down and suspended
in 5 ml of 103 50% tissue culture infective doses (TCID50)/106 cells of virus stock
in the presence of 100 mg of CHX per ml. The mixture was incubated at 378C for
1 h, and the cell clumps were dispersed every 15 min. Thirty-five milliliters of
fresh medium with 100 mg of CHX per ml was then added and incubated at 378C
for another 5 h. The cells were harvested, and RNAs were isolated by passing the
mixture through a 5.7 M CsCl cushion. For the untreated control, cells were
treated similarly except that no CHX was added.
For PAA treatment, 43 107 HSB-2 cells were treated with 300 mg of PAA per
ml for 2 h prior to the addition of 2 mg of Polybrene per ml and then incubated
at 378C for another hour. The cells were spun and suspended in 5 ml of 103
TCID50/106 cells of virus stock with 300 mg of PAA per ml. The clumps were
dispersed every 15 min. After 1 h at 378C, the cells were washed twice with RPMI
1640 medium with PAA and then suspended in 40 ml of fresh medium with
serum and PAA. Cells (20 ml each time) were harvested at 12 and 24 h, and total
RNA was isolated by the CsCl cushion method as described earlier. For the
untreated control, no PAA was added.
PCR and cloning. All the primers for PCR were designed by using the pGD41
or pCD41 sequences published previously (9, 60). The position of each primer
corresponds to the position of either the pGD41 or the pCD41 sequence. Prim-
ers for amplification and cloning of probe I are as follows: T3 primer, 59-AAT
TAACCCTCACTAAAGGG-39, and pG612 primer, 59-CAGTATATAATGTG
TTGGTCAT-39 (positions 612 to 591 of pGD41).
PCR reaction mixtures consist of 50 mM KCl, 10 mM Tris-HCl (pH 9.0), 0.1%
Triton X-100, 1.5 mM MgCl2, 20 pmol of each primer, pGD41 plasmid DNA,
0.25 mM dNTP, and 2.5 U of TaqDNA polymerase. The reaction was carried out
in a total volume of 50 ml. The first cycle was 948C for 3 min, 728C for 2 min, and
508C for 1 min 30 s; this cycle was followed by 30 cycles of 948C for 45 s, 728C for
2 min, and 558C for 1 min. The last cycle extension time at 728C for 10 min. The
PCR products were separated in a 1% agarose gel and then purified by electro-
elution.
Northern blot analyses. Northern blotting was carried out as described else-
where (7). Briefly, the RNA samples were separated in a 1.5% formaldehyde-
agarose gel and then transferred to a supported nitrocellulose membrane
(Schleicher & Schuell). The membrane was baked at 808C for 2 h, prehybridized
(in 25 mM KPO4 [pH 7.4]–53 SSC [13 SSC is 0.15 M NaCl plus 0.015 M sodium
citrate]–53 Denhardt solution–50 mg of salmon sperm DNA per ml–50% for-
mamide) at 428C for 5 h or overnight and then hybridized with a 32P-labeled
DNA probe overnight in the hybridization buffer (25 mM KPO4 [pH 7.4], 53
SSC, 53 Denhardt solution, 50 mg of salmon sperm DNA per ml, 50% form-
amide, 10% dextran sulfate). After hybridization, the membrane was washed
twice with 23 SSC–0.1% SDS at room temperature and then three times with
0.53 SSC–0.1% SDS at 658C. When oligonucleotides were used as probes,
hybridization and washing were carried out at room temperature. The membrane
was then exposed to Kodak XAR-5 film either with intensifying screens at2808C
or without screens at room temperature. RNA size was calculated by comparing
its mobility with the commercial 0.16- to 1.77-kb and 0.24- to 9.5-kb RNA ladders
(GIBCO-BRL).
Primer extension and S1 mapping. Total RNA (10 mg) was mixed with 105
cpm of 32P-end-labeled primer and then coprecipitated with ethanol. The pellet
was washed with 70% ethanol, dried briefly, and suspended in 20 ml of buffer (80
mM Tris-HCl [pH 8.3], 40 mM KCl). The mixture was heated to 908C, slowly
cooled down to 678C, and then incubated at 528C for 3 h. Reverse transcriptase
buffer (29 ml) (2.5 ml of 400 mM Tris-HCl, 2.5 ml of 400 mM KCl, 1 ml of 300 mM
MgCl2, 10 ml of 2.5 mM dNTP, 5 ml of 100 mM DTT, 2 ml of 2-mg/ml actino-
mycin D, 6 ml of H2O, 16 U of avian myeloblastosis virus reverse transcriptase
[Boehringer Mannheim]) was added, and the mixture was incubated at 428C for
1 h. After digestion with 105 ml of RNase A mixture (100 mM NaCl, 10 mM
Tris-HCl [pH 8.0], 1 mM EDTA, 20 mg of RNase A per ml) for 30 min at 378C,
the sample was extracted once with phenol-chloroform (1:1), precipitated by
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ethanol, and then analyzed on a 6% sequencing gel. A sequence reaction using
the same labeled primer was run alongside to determine the size of the primer
extension products. The gel was then dried and exposed to Kodak XAR-5 film
with intensifying screens at 2808C.
The S1 protection assay was carried out as described elsewhere (7). Briefly,
5 3 104 cpm of labeled probe was mixed with 20 mg of total RNA, and the
mixture was ethanol precipitated. The RNA pellet was briefly dried and then
suspended in 20 ml of S1 hybridization buffer {80% formamide, 40 mM PIPES
[piperazine-N-N9-bis(2-ethanesulfonic acid), pH 6.4], 400 mM NaCl, 1 mM
EDTA}. The mixture was heated to 658C for 10 min and annealed overnight at
308C. S1 digestion buffer (300 ml) (0.28 M NaCl, 50 mM sodium acetate [pH 4.5],
4.5 mM ZnSO4, 6 mg of denatured salmon sperm DNA, 150 U of S1 nuclease
[Boehringer Mannheim]) was added, and the mixture was incubated for different
times at 308C. After addition of 80 ml of S1 stop solution (4 M ammonium
acetate, 20 mM EDTA [pH 8.0], 20 mg of denatured salmon sperm DNA per ml),
1 ml of ethanol was added to precipitate the DNA. The protected products were
then separated on a 6% sequencing gel, using a sequencing reaction as marker.
DNA sequence analysis. Sequence data were obtained with the Sequenase
version 2.0 DNA sequencing kit (U.S. Biochemicals) based on the dideoxynucle-
otide termination method (47). Sequence analyses were carried out with the
Genetics Computer Group, Inc., sequence analysis package (Madison, Wis.).
RESULTS
HHV-6 variants A and B have similar transcriptional pat-
terns in the pCD41 region. Two major subgroups of HHV-6
viruses, variants A and B, have been identified (1, 2, 6, 23, 32,
51). To study the gene expression of the pCD41 gene locus, we
first determined the transcriptional patterns for both variants.
Total RNA was isolated from either variant A HHV-6(GS)-
infected HSB-2 cells or variant B HHV-6(Z29)-infected
Molt-3 cells when at least 70% of the cells displayed cytopathic
effects. For HHV-6(GS)-infected HSB-2 T cells, six RNA
bands with estimated sizes of about 4.5, 2.7, 2.3, 1.8, 1.5, and
1.2 kb were detected by the 2.1-kb pCD41 probe, with the
2.3-kb RNA species being most abundant (Fig. 1, lane 2). For
HHV-6(Z29)-infected Molt-3 cells, the pCD41 hybridization
signals were much weaker than those of HHV-6(GS), even
though an equal amount of RNA was loaded. The overall
pCD41 RNA pattern in HHV-6(Z29)-infected Molt-3 cells is
similar to those seen in the HHV-6(GS)-infected HSB-2 cells,
although the 2.3-kb RNA seems to be more predominant (Fig.
1, lane 6).
To further determine whether these pCD41 RNA species
are polyadenylated, total RNA was separated into poly(A)1
and non-poly(A) fractions, and Northern blot analyses were
performed. Several poly(A)1 RNAs with lengths of 4.7, 2.7,
2.3, 1.9, 1.5, and 1.2 kb were detected in HHV-6(GS)-infected
HSB-2 cells (Fig. 1, lane 3). Six distinct non-poly(A) RNA
species (4.5, 2.5, 2.1, 1.7, 1.4, and 1.1 kb) were also detected
(Fig. 1, lane 4). The non-poly(A) RNAs are likely to be the
immature mRNAs, because they are about 100 to 200 bases
shorter than the 4.7-, 2.7-, 2.3-, 1.9-, 1.5-, and 1.2-kb poly(A)1
mRNAs, respectively (Fig. 1, lanes 3 and 4). For the 4.5- and
1.8-kb RNA species, the RNAs in the poly(A)1 fractions (lane
3) seem larger than those in the total RNA fraction. This could
be due to rRNA interference during Northern blot analysis.
pCD41 RNAs are transcribed from one orientation. Since up
to six RNAs were detected in this region, it was important to
determine their orientations. Labeled ssDNA probes (1/2)
were prepared as described in Materials and Methods and
used in Northern analyses. Hybridization signals were detected
only with the labeled complementary strand of pCD41 (minus
strand) probe (data not shown), suggesting that all pCD41
RNAs are transcribed from the same DNA strand in the same
orientation as the pCD41 clone.
All the RNAs are polyribosome associated. To determine
whether the pCD41 RNA species can potentially be translated,
HHV-6(GS)-infected HSB-2 cells were solubilized by Nonidet
P-40 treatment and separated into cytoplasmic and nuclear
fractions to determine the subcellular localizations of pCD41
RNAs. All the RNA species could be detected in both cyto-
plasmic and nuclear fractions (data not shown). The associa-
tion of the mRNA with polyribosomes was further analyzed by
a combination of sucrose gradient and Northern analyses. The
cytoplasmic fraction from HHV-6(GS)-infected HSB-2 cells
was centrifuged through a 20 to 47% sucrose gradient in the
presence of either 5 mM MgCl2 or 10 mM EDTA. Figure 2A
shows the sedimentation profile, and Fig. 2B shows the results
of Northern analysis with pCD41 used as probe. In the pres-
ence of MgCl2, the 2.7-, 2.3-, 1.8-, 1.5-, and 1.2-kb RNA species
could clearly be detected in the polyribosomes (fractions 2 to
4) and monosome (fractions 6 to 8) fractions. A faint band at
the position of 28S rRNA was also detected in those fractions.
It is unclear whether the signal is from the 4.5-kb RNA species
or from nonspecific hybridization with 28S rRNA. In contrast,
in the presence of EDTA, the disruption of both polyribo-
somes and monosomes resulted in release of the ribosome-
associated pCD41 RNAs; the hybridization signals were mainly
detected at the ribosomal subunit fractions (Fig. 2B, lower
panel, fractions 9 to 11), and only a very weak signal remained
in the monosome fractions (fractions 6 to 8), perhaps because
of incomplete disruption of monosomes. Our results suggest
that all the pCD41 RNA species are associated with polyribo-
somes and have the potential to be actively translated.
Kinetic analysis of pCD41 mRNA expression. Herpesvirus
gene expression can be classified as IE, early, and late (20).
Expression of early genes is independent of viral DNA repli-
cation, and early genes are involved in gene regulation and
DNA replication. The late genes are dependent on viral DNA
replication and encode structural proteins (20). For the pCD41
gene locus, only the intact pCD41 transcript (2.3-kb species)
has been suggested as an early-late gene (9), while the other
species have not been studied. It is possible that some of the
smaller transcripts identified in this study belong to other
classes. To classify these RNA species, two inhibitors, CHX
and PAA, were used.
The IE transcripts are independent of other viral protein
synthesis and are initiated immediately upon virus entrance.
Therefore, CHX, a translation inhibitor, will have no effect on
the transcription of IE genes but will inhibit IE-dependent viral
FIG. 1. Northern blot analyses of HHV-6-infected T cells. (A) HHV-6 vari-
ant A strain GS-infected HSB-2 cells. (B). HHV-6 variant B strain Z29-infected
Molt-3 cells. Lanes 1 and 5, uninfected cells as negative control; lanes 2 and 6,
total RNA from infected cells; lane 3, poly(A)1 RNA purified from total RNA
with an oligo(dT) column; lane 4, unbound fraction (pass) from the oligo(dT)
purification. The size of each RNA (in kilobases) is estimated from coelectro-
phoresed RNA ladders and is indicated on the left.
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early and late genes transcription. To determine whether or
not pCD41 RNA expression is IE dependent, HHV-6(GS)-
infected HSB-2 cells were treated with CHX for 6 h, and total
RNAs were analyzed (50). Because of the inefficiency of
HHV-6 cell-free infection, poly(A)1 RNA was isolated from
100 mg of total RNA to enhance the hybridization signal (Fig.
3A). One of the characterized HHV-6 IE genes, IE 1.1, was
used as a control (50). For the IE 1.1 gene, only the 3.6-kb IE
1.1 transcript could be seen clearly in both CHX-treated and
untreated cells, although a slight reduction in signal was ob-
served in the treated samples. For the pCD41 panel, with the
same amount of total RNA, no signal differentiable from that
of the uninfected cell was detected (Fig. 3A, lanes t). This
result indicates that very little expression from the pCD41
locus occurred at 6 h p.i. Thus, none of the pCD41 RNAs could
be classified as an IE gene. However, the 4.5-, 2.3-, and 1.8-kb
RNA species were detectable in the poly(A)1 RNA (Fig. 3A,
lanes m), but after prolonged exposure, this could be due to
incomplete inhibition by CHX. To confirm that an equal
amount of RNA was loaded in each sample, the membranes
were stripped and then rehybridized with a b-actin probe. No
difference was observed between untreated and treated RNA
samples.
PAA can inhibit the replication of HHV-6 DNA and prevent
late-gene expression (3, 9, 12). To determine whether any
pCD41 species are expressed in late infection, total RNAs
were isolated from HHV-6(GS)-infected HSB-2 cells treated
with PAA and then analyzed by Northern blotting (Fig. 3B). At
12 and 24 h p.i., all the different pCD41 RNAs species could be
detected in both PAA-treated and untreated controls, but the
intensity of the signal was much lower in treated cells than in
the untreated control. This indicates that expression of all the
different pCD41 RNAs is significantly but incompletely inhib-
ited by PAA treatment. The incomplete inhibition also sug-
gests that some transcription of the pCD41 locus can occur
prior to viral DNA synthesis. For IE 1.1 gene expression
(which should be independent of viral DNA syntheses at the
early infection), the expression of the 3.6-kb transcripts was
also slightly inhibited by PAA. b-Actin transcript was again
used as an internal control, and no inhibition of the actin RNA
FIG. 2. Polyribosome association of pCD41 RNA. (A) Sedimentation profile
of a detergent-solubilized cytoplasmic lysate in a 20 to 47% (wt/wt) sucrose
gradient with either MgCl2 or EDTA. A fraction (1 ml) was collected from the
bottom of the tube, and the absorbency (OD260) was measured. Polyribosome
and monosome peaks are indicated. (B) Northern analyses of RNA from equal
volumes of each fraction. U, unfractionated RNA control. The size of each RNA
(in kilobases) is shown on the left.
FIG. 3. CHX and PAA inhibition of pCD41 transcription. (A) RNAs were
isolated from CHX-treated (1CHX) or untreated (2CHX) HHV-6(GS)-in-
fected cells at 6 h p.i., and Northern blotting was carried out with either IE 1.1
or pCD41 as probe. Lanes: t, 10 mg of total RNA; m, poly(A) RNA isolated from
100 mg of total RNA. (B) RNAs were isolated from PAA treated (1) or un-
treated (2) HHV-6(GS)-infected cells at 12 or 24 h p.i., and Northern blotting
was carried out with either IE 1.1 or pCD41 as probe. Lanes: GS, 1 mg of total
RNA from HHV-6(GS)-infected HSB-2 was used as positive control; HSB-2,
uninfected HSB-2 cells were used as negative control. b-actin, stripped mem-
branes were rehybridized with a b-actin probe to monitor the RNA content in
each lane.
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was observed. The early initiation and incomplete inhibition by
PAA suggests that all the RNA species in the pCD41 locus
should be classified as early-late transcripts. This observation
corresponds well with the HCMV UL44 early-late gene ex-
pression (11, 29). The expression of the HCMV 51-kDa pro-
tein encoded by UL44 begins prior to that of most other viral
proteins but requires preceding viral proteins and DNA repli-
cation (11, 29). The synthesis of the p41 protein at this time
corresponds to its role as an accessory protein for viral DNA
replication.
Mapping the pCD41 RNA species. In order to determine the
approximate position of each pCD41 transcript, six pCD41
fragments (EcoRI-MstII [II],MstII-AsuII [III], AsuII-NsiI [IV],
NsiI-PvuII [V], PvuII-BglII [VI], and BglII-EcoRI [VII]) were
used as probes for Northern blot analyses. In addition, one
PCR product, T3-612 (I), was used to detect possible transcrip-
tion initiated upstream of the pCD41 gene locus (Fig. 4 and 5).
When the intact p41 cDNA was used as a control in hybrid-
ization, the RNA species detected (Fig. 4, lanes 2 and 10 to 12)
were similar to those observed earlier (Fig. 1, lanes 1 to 4). The
hybridization pattern of probe I is different from that of
pCD41 (Fig. 4, lane 3). Besides the 4.5- and 2.7-kb RNAs, two
new RNAs species with molecular sizes of 3.0 and 0.8 kb were
also detected. The newly detected RNA species could be the
transcripts of other ORFs upstream of pCD41 and initiated
from outside the pGD41 locus. These transcripts are unlikely
to encode either the trans-activating protein or the viral acces-
sory protein and were not pursued further in this study. Other
RNA species detected by the pCD41 probe, such as the 2.3-,
1.8-, 1.5-, and 1.2-kb RNA species, did not hybridize to probe
I, suggesting that they are initiated within the pCD41 region.
When probe II was used for hybridization, four RNA species
(4.5-, 2.7-, 2.3-, and 1.5-kb RNAs) could be detected (Fig. 4,
lane 4). Since the 2.3- and 1.5-kb RNA species were not de-
tected by probe I, this result indicates that the 2.3- and 1.5-kb
RNA species may be initiated within the probe II region (Fig.
4 and 5). Hybridization with probes III (Fig. 4, lane 5) and IV
(Fig. 4, lane 6), gave similar patterns, and the 1.8-kb RNA was
detected in addition to those observed with probe II, suggest-
ing that the 1.8-kb RNA species is initiated within the probe III
region. Hybridization with probe V (Fig. 4, lane 7) showed a
pattern similar to that of the entire pCD41 insert probe, and all
the RNA species were detected. The hybridization patterns for
probes VI and VII were also very similar: all poly(A)1 RNAs
except the 1.5-kb RNA were observed (Fig. 4, lanes 8 and 9).
This suggests that the 1.5-kb RNA encodes only the ORF A
region of pCD41 (Fig. 4 and 5). Fragment VII is only 150 bp in
length and contains the poly(A) signal; hybridization of the
2.7-, 2.3-, 1.8-, and 1.2-kb RNAs with this probe suggests that
these RNAs have a common poly(A) signal.
The hybridization results allowed approximate mapping of
all the RNA species in the pCD41 locus except the 4.5-kb
RNA. Hybridization of the 4.5-kb RNA with all the probes
indicates that this RNA is transcribed through the pCD41 and
possibly the pGD41 region (Fig. 4 and 5). The 4.5-kb RNA,
which is about twice the size of the pCD41 transcript, must be
initiated far beyond our pCD41 and pGD41 loci. Thus, it is
difficult to further narrow down its putative 59 and 39 ends with
the probes employed here. In addition, a 4.5-kb RNA is un-
likely to encode either the 41-kDa accessory protein or the
FIG. 4. Mapping of the approximate position of each RNA. Schematic diagrams of pCD41, pGD41, and the probes (I to VII) used in Northern hybridization are
shown at the top. HHV-6(GS)-infected HSB-2 total RNA (10 mg) was hybridized with intact pCD41 probe or probe I (lanes 2 and 3). pCD41 hybridization was used
to determine the position of each RNA detected by probe I hybridization. Poly(A) RNA obtained from 10 mg of HHV-6(GS)-infected HSB-2 total RNA (lanes 4 to
9) was hybridized with probes II to VII, respectively. To precisely locate each RNA, pCD41 hybridization was also carried out as markers (lanes 10, 11, and 12). 2,
uninfected HSB-2 cells; T, total RNA from HHV-6-infected cells; m, poly(A) RNA; p, non-poly(A) RNA. The size of each RNA (in kilobases) is indicated on both
sides of the gels.
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trans-activating protein. The initiation site of this transcript
was not pursued further.
Mapping the 5* end of the pCD41 RNA species. On the basis
of fragment hybridization results and the size of each RNA,
four primers were designed for primer extension and S1 map-
ping assays in order to map precisely the various pCD41 RNA
species (Fig. 4 and 5). To determine the specificity of each
primer for the different pCD41 RNA species, Northern blot
analyses were conducted with the labeled primers as probes.
The primer PG612 hybridization pattern is different from
that obtained with probe I (Fig. 6B; Fig. 4, lane 3). Three RNA
species of 4.5, 3.0, and 2.7 kb were detected with primer
PG612, but the 0.8-kb RNA species was not detectable. This
suggests that the 0.8-kb RNA species terminated within probe
I and upstream of the primer. It is interesting that both the 3.0-
and 2.7-kb RNAs could be detected when the 22-bp primer
PG612 was used as probe. Probe I hybridization results suggest
that the signal intensity between two RNAs is similar and that
nearly equal amounts of the two RNA species persist in the
total RNA (Fig. 4, lane 3). However, in the primer PG612
hybridization, the relative intensities of 3.0- and 2.7-kb RNAs
are very different. Sequence analyses have shown that the 39
end of the U28 gene is located in the primer PG612 region and
could partially hybridize to the primer PG612. Therefore, our
primer hybridization data confirm that the 3.0-kb RNA is the
U28 gene transcript, and it was not pursued further in this
study. Besides the 4.5- and 2.7-kb RNAs, other RNA species
detected by pCD41 were not found by the PG612 primer,
confirming that all of them were initiated downstream of the
PG612.
To map precisely the 59 end of the 2.7-kb RNA, primer
extension and S1 mapping assays were carried out with PG612
primer and S1 probe (Fig. 6A). Two distinct protected bands at
nucleotides (nt) 229 and 255 of pGD41 were detected by S1
analysis (Fig. 6C, lane 8). In the primer extension assay, two
similar bands were also observed (Fig. 6C, lane 6). Both primer
extension and S1 mapping results indicate that the 2.7-kb RNA
may have two start sites located at nt 229 and 255 of pGD41
and that no splicing occurs in this mapped region.
Primer PC123 hybridized to the 4.5-, 2.7-, 2.3-, and 1.5-kb
RNAs, suggesting that the 59 ends of the 2.3- and 1.5-kb RNA
species are located upstream of the primer (Fig. 5 and 7B). To
precisely map the 59 ends of these RNAs, primer extension and
S1 mapping were carried out with the PC123 primer and the S1
probe (Fig. 7A). Two predominant bands at positions 113 and
114 were observed with the primer extension assay. This sug-
gests that the 2.3- and 1.5-kb poly(A)1 RNAs initiate from the
same sites at positions 113 and 114 of the pCD41 sequence
(Fig. 7C, lane 6). These RNA initiation sites were further
confirmed by S1 analysis. Although several bands were ob-
served with the S1 mapping result, the most intense bands were
at the same positions as those shown by the primer extension
(Fig. 7C, lane 8). The mapping of the 59 end for both 2.3- and
1.5-kb RNA species by both primer extension and S1 protec-
tion suggests that no splicing had occurred in the analyzed
region.
To map the 59 end of 1.8-kb RNA, a second primer, PC565,
was used (Fig. 5 and 8A). This primer hybridized to 4.5-, 2.7-,
2.3-, and 1.5-kb RNA species in addition to the 1.8-kb RNA
(Fig. 8B). The hybridization of 1.8-kb RNA to primer PC565
FIG. 5. Schematic representation of the organization and transcription pattern of the pCD41 locus. Numbers indicate the nucleotide positions according to the
pCD41 or pGD41 sequence. The locations of the RNA start sites are indicated in front of each RNA species; for the 2.7-kb species, the RNA starts at positions
1229/255 with respect to the pGD41 sequence; the 2.3-kb species starts at RNA nt 113 with respect to the pCD41 sequence. The putative ORFs encoded by the RNA
are shown by shaded boxes; the AUGs represent the potential start sites, and their nucleotide locations with respect to the pCD41 sequence are indicated. , AUG
codon located on the RNA that cannot initiate any functional protein. Arrowheads indicate the primers that were used to analyze the 59 end of each RNA. Multiple
A’s at the 39 end of the RNA indicates polyadenylation.
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but not primer PC123 suggests that the 59 end of the 1.8-kb
RNA is between the two primers (Fig. 5). A band at position
1468 and a very faint band at position 1443 were detected by
primer extension assay (Fig. 8C, lane 6). One intense band and
two weaker bands were detected by S1 mapping (Fig. 8C, lane
8). Since the primer extension band corresponds to the intense
S1 protection band at position 1468, its presence suggests that
the 1.8-kb RNA was initiated at position 1468 on the pCD41.
The very faint band at position1443 did not correspond to any
bands detected by S1 and is likely to have been caused by
premature termination during primer extension. Besides the
1468 primer extension band, a weaker band at approximately
position 113 was also detected by primer PC565 (data not
shown). This corresponds to the start sites of the 2.3- and
1.5-kb RNAs mapped by PC123 and indicates that no splicing
occurs upstream of PC565.
The last primer, PC1449, hybridized to all the poly(A)1
RNA species but not to the 1.5-kb RNA (Fig. 5 and 9B). Since
it is the only tested primer that hybridized to the 1.2-kb
poly(A)1 RNA, this primer was used in primer extension stud-
ies to map the 59 end of the 1.2-kb RNA (Fig. 9A and C).
Because of interference by other predominant RNA species,
higher background bands were seen in the primer extension
assay and no consistent predominant band was detected. Since
no definite band was detected by primer extension, S1 analysis
was performed. Two bands at positions11294 and11295 were
consistently detected in the S1 mapping assays, suggesting that
the 59 end of the 1.2-kb poly(A)1 RNA is likely to be at
position 11294 or 11295.
Mapping the 3* end of the 1.5-kb RNA species. The 1.5-kb
RNA species can hybridize to probe V but not to downstream
probes VI and VII, suggesting that the 39 end, poly(A) site, or
splice site may be located within the probe V region (Fig. 4 and
5). To determine the locations of the 39 ends of 1.5-kb RNA,
S1 analyses were used (Fig. 10). Multiple protected bands were
observed with the HHV-6(GS)-infected RNA (lanes 2 and 4)
but not with the negative control RNA (lanes 1 and 3). The
longest protected band is 128 bases long and is located at
positions11348 on the pCD41 sequence. Since sequence anal-
yses did not reveal any splice donor sites within this region, it
is likely that the protected site is the 39 end of the 1.5-kb
poly(A)1 RNA rather than a splice donor site.
DISCUSSION
The herpesvirus DNA polymerase accessory proteins, such
as the UL42 protein in herpes simplex virus type 1, the BMRF1
gene product of Epstein-Barr virus (EBV), and the UL44 gene
product in cytomegalovirus, have been shown to be very im-
portant for viral replication (10, 15, 18, 38, 41, 44, 45, 52) and
to be involved in gene regulation. For example, the EBV
FIG. 6. Mapping the 2.7-kb RNA initiation sites. (A) Schematic representa-
tion of the primer and S1 probe used in the assays and summary of mapping
results. (B) Northern hybridization was carried out with labeled primer PG612.
(C) Initiation sites of 2.7-kb transcript identified by both primer extension and S1
mapping. The sizes of the primer extension products and S1 protected fragments
are indicated by a homologous sequencing ladder initiated with the same primer.
The positions of the products are indicated by arrows and numbered according
to the positions on the pGD41 sequence. GS, total RNA isolated from HHV-
6(GS)-infected HSB-2 cells; PE, primer extension; S1, S1 mapping.
FIG. 7. Mapping the 2.3- and 1.5-kb RNA initiation sites. (A) Schematic
representation of the primer and S1 probe used in the assays and summary of the
mapping results. (B) Northern hybridization was carried out with labeled primer
PC123. (C) Initiation sites of 2.3-kb transcript identified by both primer exten-
sion and S1 mapping. The sizes of the primer extension products and S1 pro-
tected fragments are indicated by a homologous sequencing ladder initiated with
the same primer. The positions of the products are indicated by arrows and
numbered according to the positions on the pCD41 sequence. The abbreviations
are the same as those in the legend for Fig. 6.
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BMRF1 gene fragment was reported to activate transcription
of the simian virus 40 promoter (40); antisense mRNA to the
UL44 transcripts was shown to have an affect on both viral
replication and b1 gene expression in an astrocytoma cell line
(45). For the analogous U27 gene in HHV-6, we have demon-
strated that its gene product p41 protein of HHV-6 can trans-
activate the HIV promoter (60). Thus, these accessory proteins
could play important roles in viral gene regulation and DNA
replication.
Gene expression in herpesvirus accessory gene loci appears
to be extremely complex. Multiple transcripts have been de-
tected in the herpesviral DNA polymerase accessory protein
gene loci (4, 9, 29, 41, 43, 56, 57). Generally, three or four
nonspliced RNA species of different sizes were found to initi-
ate at different positions. The largest and smallest RNAs are
minor species, and their functions are unclear; the predomi-
nant medium-size RNAs are the coding transcripts for acces-
sory protein. For example, for the EBV BMRF1 locus, three
different sizes of RNA (3.5, 2.7, and 1.5 kb) were found to
hybridize to the BMRF1 cDNA, which encodes the 50-kDa
EBV accessory protein (10, 43). In the HCMV UL44/ICP36
locus, four RNA species of about 8.0, 4.8, 3.2, and 2.0 kb were
detected by Northern hybridization (29, 41, 56, 57). In this
study, the HHV-6 accessory gene locus was extensively studied,
and at least six different sizes of RNA species could be de-
tected. It appears that the multiple transcriptional patterns in
these gene loci may be important for viral gene regulation or
expression. Therefore, further investigation of these RNA
functions is very important for understanding regulation in this
accessory protein region.
Our total RNA blot results have shown that at least six
different RNA species could be detected by the pCD41 probe
from both HHV-6 variant A or B virus-infected cells. Although
the relative amounts of RNA expressed by the two variants are
slightly different, their transcriptional patterns are very similar.
The RNA pattern shown in this study supports our previous
observation (9) but differs slightly from that in a report by
Agulnick et al. (4), who detected only the 2.7-, 2.1-, and 1.7-kb
RNA species for the pCD41 locus. These could be due to the
use of different probes in the Northern analyses. Our probe,
pCD41, contains both ORF A and ORF B regions, while theirs
contains only the ORF A, the p41 coding region.
We have identified several RNA species (2.7, 2.3, 1.8, 1.5
and 1.2 kb) that can potentially encode the HHV-6 accessory
and trans-activation protein. Other species, such as 4.5-, 3.0-,
and 0.8-kb RNAs, are either expressed beyond the pCD41
locus or initiated far upstream from the pCD41 region and
were therefore not extensively studied in this work. Unlike
other pCD41 transcripts, the 2.7-kb RNA initiates from two
different positions (at nt 229 and 255) in the middle of the large
FIG. 8. Mapping the 1.8-kb RNA initiation site. (A) Schematic representa-
tion of the primer and S1 probe used in the assays and summary of the mapping
results. (B) Northern hybridization was carried out with labeled primer PC565.
(C) Initiation sites of 1.8-kb transcript identified by both primer extension and S1
mapping. The sizes of the primer extension products and S1 protected fragments
are indicated with a homologous sequencing ladder initiated with the same
primer. The positions of the products are indicated by an arrow and numbered
according to the positions on the pCD41 sequence. The abbreviations are the
same as those in the legend to Fig. 6.
FIG. 9. Mapping the 1.2-kb RNA initiation site. (A) Schematic representa-
tion of the primer and S1 probe used in the assays and summary of the mapping
results. (B) Northern hybridization was carried out with labeled primer PC1449.
(C) Initiation sites of 1.2-kb transcript identified by both primer extension and S1
mapping. The sizes of the primer extension products and S1 protected fragments
are indicated by a homologous sequencing ladder initiated with the same primer.
The positions of the products are indicated by arrows and numbered according
to the positions on the pCD41 sequence. The abbreviations are the same as those
in the legend to Fig. 6.
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subunit of the ribonucleotide reductase gene (U28) (17, 58).
One putative TATA box sequence (224-TATTAAA-230) is
located at the optimal position for the RNA initiated at nt 255.
However, no such sequences could be found upstream of the
RNA initiation site at nt 229, although an AT-rich region exists
in that region. These results imply that viral specific or other
unidentified sequences may be important for transcription ini-
tiation at nt 229. Since several AUGs (positions 1251 and
1287) immediately downstream of both initiation sites of the
2.7-kb RNA cannot encode either the U28 ORF or the p41
protein, and since no splicing occurs in the 2.7-kb RNA, it is
unlikely that this RNA can encode either U28 or the p41
protein, and the function of this RNA is still unclear. However,
we cannot eliminate the possibility that an AUG further down-
stream (at position 163 of ORF A; Fig. 5) may be used to
translate part of the p41 ORF. The 2.3- and 1.5-kb RNAs
initiate at nt 113 or 114 of the pCD41 sequence, one nucle-
otide upstream of a previous report mapping a 2.5-kb RNA
expressed from this region (58). While the 2.3-kb RNA can
potentially encode for both ORF A and ORF B, it is unclear
whether it is a bicistronic mRNA that can encode both ORFs.
Although the 1.5-kb RNA initiates at the same position as the
2.3-kb RNA, it terminates earlier and therefore encodes only
ORF A. Therefore, our mapping results suggest that the 2.3-
and 1.5-kb poly(A)1 RNAs are the most likely transcripts for
the p41 protein, which contains both accessory and trans-acti-
vation functions. The potential AUG at position 163 could be
the initiation codon for the p41 protein. The 1.8-kb RNA does
not seem to code for any protein, because the first two AUGs
(positions 1571 and 1581) downstream of its 59 end can en-
code only a few amino acids, although this RNA is polyribo-
some associated. However, it is still possible that internal
AUGs further downstream could be used to encode truncated
forms of the p41 protein, as suggested by our previous study
(60). This RNA did not initiate from any of the TATA se-
quences as predicted earlier (60), and no typical promoter
sequence was found in its upstream sequences. This suggests
that the expression of this RNA may be regulated differently,
possibly by viral transcriptional factors.
Because there are six overlapping RNA species in a 2.1-kb
region, it is difficult to map certain RNA species precisely,
especially the 1.2-kb RNA. The primers or probes that were
used for the detection of 1.2-kb RNA also hybridized to the
other RNAs, such as the predominant 2.3-kb species, causing
lower specific signals and higher nonspecific background. Thus,
for this RNA, only consistent bands shown in different exper-
iments were considered. Although no TATA box sequence was
found upstream of the 1.2-kb RNA, an AP2 binding site is
present at nucleotide positions 1248 to 1257 of pCD41. A
protein of 168 amino acids can potentially be encoded by the
1.2-kb poly(A)1 RNA, but so far, no HHV-6-specific or ho-
mologous gene product from other herpesviruses has been
identified.
The DNA fragment hybridization results suggest that 2.7-,
2.3-, 1.8-, and 1.2-kb RNA species use the same poly(A) signal
sequence. For the 1.5-kb RNA, the 39 end was mapped to
position 11348, and it probably uses a different poly(A) signal
site. Sequence analyses have shown a poly(A) signal-like se-
quence (TATAAA) about 20 bases upstream of the mapped
position (Fig. 10C). It is possible that this rare poly(A) signal
has a lower efficiency and was used to generate a minor 1.5-kb
transcript. A rare poly(A) signal (ATTAAA) is used by the
EBV BMRF1 gene, which encodes the EBV accessory protein
(10). Because of the overlap between the 39 end of the 1.5-kb
RNA and the 59 end of the 1.2-kb RNA, it is also possible that
the initiation or transcription of the 1.2-kb RNA may interfere
with the transcription of the 2.3-kb RNA and cause early ter-
mination of the 2.3-kb transcript, leading to generation of the
1.5-kb RNA.
Our data and previous results suggest that the p41 protein
could be encoded by either the 2.3- or the 1.5-kb RNA. Re-
cently, the promoter for the 2.3- or 1.5-kb RNA was charac-
terized to determine how this protein is regulated (58). This
promoter is almost silent without viral infection but is highly
active in infected cells. This finding suggests that the transcrip-
tion of the p41 RNA is regulated by viral proteins. Our kinetic
studies have shown that the RNAs should be classified as the
early-late gene and supported the idea that the p41 promoter
is under viral regulation. Besides the viral factor(s), four dif-
ferent cellular factors (C1 through C4) have been reported to
bind to the p41 promoter in a mobility shift assay (58). The
results indicate that in infected cells, transcriptional stimula-
tion of the pCD41 promoter requires C1 and C2 binding ac-
tivities and possible C3 and C4 elimination. Therefore, besides
the viral regulators, cellular factors may play a very important
role in the regulation of this gene locus. The CHX inhibition
results indicate that pCD41 RNA synthesis is not detectable at
6 h p.i., when IE genes are expressed. In addition, the PAA
inhibition results show that all the pCD41 RNA species are
significantly but incompletely inhibited by PAA treatment at 12
and 24 h p.i. All those data suggest that the continued synthe-
ses of all the pCD41 RNAs depend on viral DNA replication.
This observation corresponds well with the HCMV UL44 ear-
FIG. 10. Determination of the 39 end of 1.5-kb RNA. (A) Schematic repre-
sentation of the S1 probe used in the assay and summary of the mapping results.
(B) The 39 end of the 1.5-kb RNA was identified by S1 mapping. The sizes of the
S1 protected fragments are indicated by an M13mp18 sequencing ladder initi-
ated with the 240 primer. The positions of the products are indicated by an
arrow. Lane 1, 10 mg of total RNA from uninfected HSB-2 cells; lane 2, 10 mg of
total RNA from HHV-6(GS)-infected HSB-2 cells; lane 3, poly(A) RNA sepa-
rated from 10 mg of uninfected HSB-2 total RNA; lane 4, poly(A) RNA sepa-
rated from 10 mg of HHV-6(GS)-infected HSB-2 total RNA. (C) Sequences of
the region containing the 2.3- and 1.5-kb RNA poly(A) signals. The putative
poly(A) signals are underlined and in boldface type. Arrows indicate the putative
sites at which poly(A) polymerase adds poly(A).
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ly-late gene expression (29). The expression of a 51-kDa
HCMV UL44 protein begins prior to that of most other viral
proteins but requires preceding viral proteins and DNA repli-
cation. Furthermore, we have shown that in the presence of
PAA, p41 protein is significantly reduced in amount but not
abolished in the HHV-6 infected cells (9). Because both the
accessory protein and HIV LTR trans-activating protein have
been mapped to the pCD41 ORF A region, further under-
standing of the regulation of the accessory gene locus may
provide important information about viral replication and reg-
ulation of viral gene expression.
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